David G. Livermore

569 citations

17 papers · 362 indexed · h-index 11

Co-authors: Michael Allen Paul G. Wyatt Fabrizio Nerozzi P.M. Woollard Anne M. Exall Alan D. Borthwick M.J. Perren Shilina Roman
Topics: Neuroendocrine regulation and behavior (6 papers)Organic and Inorganic Chemical Reactions (4 papers)Biochemical and Molecular Research (3 papers)
Cited by: Physiology Endocrine and Autonomic Systems Organic Chemistry
Journals: Journal of Medicinal Chemistry Antimicrobial Agents and Chemotherapy British Journal of Pharmacology
Partner nations: United Kingdom United States Germany

In The Last Decade

David G. Livermore

17 papers receiving 350 citations

Peers

Countries citing papers authored by David G. Livermore

Since Specialization

Citations

This map shows the geographic impact of David G. Livermore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Livermore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Livermore more than expected).

Fields of papers citing papers by David G. Livermore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Livermore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Livermore. The network helps show where David G. Livermore may publish in the future.

Co-authorship network of co-authors of David G. Livermore

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Livermore. A scholar is included among the top collaborators of David G. Livermore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Livermore. David G. Livermore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist 2024 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Roland W. Bürli,David G. Livermore,(unknown),(unknown),(unknown),Robert G. Newman,(unknown),David J. Miller,Lee A. Dawson,Kim L. Matthews,Mark Carlton,Nicola Brice	7
2	1,2,4-Triazolo-[1,5-a]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction 2017 ·Journal of Medicinal Chemistry ·Saleh A. Ahmed,Andrew Ayscough,(unknown),(unknown),Richard Davenport,Robert Downham,David Harrison,Kerry Jenkins,(unknown),David G. Livermore,(unknown),Anthony Ivetac,R.J. Skene,Steven J. Wilkens,Natalie Webster,Alan G. Hendrick	28
3	Synthesis and structure–activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Alexander J. Stevens,(unknown),Anton D. Michel,Daryl S. Walter,D.J.G. Davies,David G. Livermore,Elena Fonfría,Emmanuel H. Demont,(unknown),Pam Theobald,Paul Beswick,Robert J. Gleave,Shilina Roman,Stefan Senger	21
4	Pyrazolopyridazine alpha-2-delta-1 ligands for the treatment of neuropathic pain 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Mark P. Healy,Gianpaolo Bravi,Andrew Billinton,Christopher N. Johnson,Kim L. Matthews,Karamjit S. Jandu,Wenjing Meng,Anne Hersey,David G. Livermore,(unknown),Jason Witherington,Rino A. Bit,James E. Rowedder,Jason Brown,Nick M. Clayton	12
5	2-Amino-5-aryl-pyridines as selective CB2 agonists: Synthesis and investigation of structure–activity relationships 2009 ·Bioorganic & Medicinal Chemistry Letters ·Robert J. Gleave,Paul Beswick,Andrew J. Brown,Gerard M.P. Giblin,Carl Haslam,David G. Livermore,(unknown),Neville Nicholson,Lee W. Page,Brian P. Slingsby,Martin E. Swarbrick	9
6	Identification of regions of the P2X₇receptor that contribute to human and rat species differences in antagonist effects 2008 ·British Journal of Pharmacology ·A.D. Michel,William C. Clay,(unknown),Shilina Roman,(unknown),J. Patrick Condreay,Matthew D. Hall,Joanna D. Holbrook,David G. Livermore,Stefan Senger	45
7	Identification and optimization of novel 1,3,4-oxadiazole EP1 receptor antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Susan H. Brown,A. R. Chowdhury,Gerard M.P. Giblin,(unknown),Mark P. Healy,David G. Livermore,Richard J. Wilson,Alan Naylor,(unknown),Shilina Roman,Emma Ward,(unknown)	16
8	7 Oxytocin Antagonists as Potential Therapeutic Agents for the Treatment of Preterm Labour 2006 ·Progress in medicinal chemistry ·Michael Allen,David G. Livermore,J.E. Mordaunt	7
9	2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists. 3. Synthesis, Pharmacokinetics, and in Vivo Potency 2006 ·Journal of Medicinal Chemistry ·Alan D. Borthwick,(unknown),Anne M. Exall,Richard J. D. Hatley,Jennifer Hughes,Wendy R. Irving,David G. Livermore,(unknown),Fabrizio Nerozzi,Klára Valkó,Michael Allen,M.J. Perren,(unknown),P.M. Woollard,Mark Price	34
10	2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: identification, stereochemistry and initial SAR 2005 ·Bioorganic & Medicinal Chemistry Letters ·Paul G. Wyatt,Michael Allen,Alan D. Borthwick,(unknown),Anne M. Exall,Richard J. D. Hatley,Wendy R. Irving,David G. Livermore,Neil D. Miller,Fabrizio Nerozzi,(unknown),Anna Katrin Szardenings	50
11	2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists. 2. Synthesis, Chirality, and Pharmacokinetics 2005 ·Journal of Medicinal Chemistry ·Alan D. Borthwick,(unknown),Anne M. Exall,David G. Livermore,(unknown),Fabrizio Nerozzi,Michael Allen,M.J. Perren,(unknown),P.M. Woollard,Paul G. Wyatt	39
12	Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives 2002 ·Bioorganic & Medicinal Chemistry Letters ·Paul G. Wyatt,Michael Allen,(unknown),C. Gardner,David G. Livermore,(unknown),Fabrizio Nerozzi,(unknown),M.J. Perren,Gordon G. Weingarten,(unknown),P.M. Woollard,Ping Zhou	36
13	Identification of potent and selective oxytocin antagonists. Part 1: indole and benzofuran derivatives 2002 ·Bioorganic & Medicinal Chemistry Letters ·Paul G. Wyatt,Michael Allen,(unknown),Alison J. Foster,David G. Livermore,(unknown),Jan Scicinski,P.M. Woollard	27
14	A versatile procedure for the generation of nucleoside 5′-carboxylic acids using nucleoside oxidase 1998 ·Tetrahedron ·Mahmoud Mahmoudian,Brian A.M. Rudd,Brian J. Cox,(unknown),Richard M. Hall,Paul Stead,Michael J. Dawson,Malcolm Chandler,David G. Livermore,Nicholas J. Turner,Gareth Jenkins	10
15	Synthesis of novel monocyclic squalestatin analogues as potential inhibitors of squalene synthase 1994 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Gerard M.P. Giblin,David G. Livermore,(unknown),Carl Smith,(unknown)	5
16	Antifungal properties in a novel series of triazino[5,6-b]indoles 1993 ·Antimicrobial Agents and Chemotherapy ·O. S. KINSMAN,David G. Livermore,Candice A. Smith	15
17	Cobaloximes. Part 2. A modified Schrauzer synthesis for base-sensitive cobaloximes 1982 ·Journal of the Chemical Society Perkin Transactions 1 ·David G. Livermore,David A. Widdowson	1

About David G. Livermore

David G. Livermore is a scholar working on Physiology, Endocrine and Autonomic Systems and Microbiology, having authored 17 papers that have together received 362 indexed citations. Recurring topics across this work include Neuroendocrine regulation and behavior (6 papers), Organic and Inorganic Chemical Reactions (4 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Physiology (55 citations), Endocrine and Autonomic Systems (41 citations) and Organic Chemistry (167 citations). David G. Livermore has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Michael Allen, Paul G. Wyatt, Fabrizio Nerozzi, P.M. Woollard, Anne M. Exall, Alan D. Borthwick, M.J. Perren, Shilina Roman, Wendy R. Irving and Richard J. D. Hatley. Their work appears in journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact